MEDTR.E — Meditera Tibbi Malzeme Sanayi ve Ticaret AS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Market Cap
TRY3.30bn
Enterprise Value
TRY2.93bn
Revenue
TRY2.09bn

Annual balance sheet for Meditera Tibbi Malzeme Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	55.7	395	600	614	434
Net Total Accounts Receivable
Net Total Receivables	116	138	274	459	462
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	241	618	1,207	1,560	1,553
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	89.5	85.2	548	1,094	1,169
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	342	719	1,890	2,733	2,810
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	87.6	127	240	411	459
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	125	150	383	605	580
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	217	569	1,506	2,128	2,230
Total Liabilities & Shareholders' Equity	342	719	1,890	2,733	2,810
Total Common Shares Outstanding